BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27027260)

  • 1. TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells.
    Deng W; Wang J; Zhang J; Cai J; Bai Z; Zhang Z
    IUBMB Life; 2016 May; 68(5):355-64. PubMed ID: 27027260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-ANRIL promotes gastric cancer progression by enhancing NF-kB signaling.
    Deng W; Zhang Y; Cai J; Zhang J; Liu X; Yin J; Bai Z; Yao H; Zhang Z
    Exp Biol Med (Maywood); 2019 Sep; 244(12):953-959. PubMed ID: 31242038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of long non-coding RNA ANRIL inhibits tumorigenesis in human gastric cancer cells via microRNA-99a-mediated down-regulation of BMI1.
    Liu P; Zhang M; Niu Q; Zhang F; Yang Y; Jiang X
    Braz J Med Biol Res; 2018 Aug; 51(10):e6839. PubMed ID: 30156609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR‑500a‑3p/XBP‑1 axis.
    Zhou Y; Sha Z; Yang Y; Wu S; Chen H
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
    Nie FQ; Sun M; Yang JS; Xie M; Xu TP; Xia R; Liu YW; Liu XH; Zhang EB; Lu KH; Shu YQ
    Mol Cancer Ther; 2015 Jan; 14(1):268-77. PubMed ID: 25504755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of lncRNA ANRIL inhibits the development of cisplatin resistance by upregulating miR‑98 in lung cancer cells.
    Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
    Oncol Rep; 2020 Sep; 44(3):1025-1036. PubMed ID: 32705261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The silencing of long non-coding RNA ANRIL suppresses invasion, and promotes apoptosis of retinoblastoma cells through the ATM-E2F1 signaling pathway.
    Yang Y; Peng XW
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TET2 functions as a resistance factor against DNA methylation acquisition during Epstein-Barr virus infection.
    Namba-Fukuyo H; Funata S; Matsusaka K; Fukuyo M; Rahmutulla B; Mano Y; Fukayama M; Aburatani H; Kaneda A
    Oncotarget; 2016 Dec; 7(49):81512-81526. PubMed ID: 27829228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma.
    Ren S; Xu Y
    Cancer Sci; 2019 May; 110(5):1621-1632. PubMed ID: 30888082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ANRIL promotes the malignant progression of cholangiocarcinoma by epigenetically repressing ERRFI1 expression.
    Yu Y; Chen Q; Zhang X; Yang J; Lin K; Ji C; Xu A; Yang L; Miao L
    Cancer Sci; 2020 Jul; 111(7):2297-2309. PubMed ID: 32378752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
    Ma J; Li T; Han X; Yuan H
    J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten-eleven translocation 2 demethylates the
    Li X; Wu C; Shen Y; Wang K; Tang L; Zhou M; Yang M; Pan T; Liu X; Xu W
    J Biol Chem; 2018 Jun; 293(26):10059-10070. PubMed ID: 29773648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
    Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
    Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Noncoding RNA ANRIL Supports Proliferation of Adult T-Cell Leukemia Cells through Cooperation with EZH2.
    Song Z; Wu W; Chen M; Cheng W; Yu J; Fang J; Xu L; Yasunaga JI; Matsuoka M; Zhao T
    J Virol; 2018 Dec; 92(24):. PubMed ID: 30258009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
    Hu X; Jiang H; Jiang X
    Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA ANRIL promotes cell growth, migration and invasion of hepatocellular carcinoma cells via sponging miR-144.
    Ma Y; Zhang H; Li G; Hu J; Liu X; Lin L
    Anticancer Drugs; 2019 Nov; 30(10):1013-1021. PubMed ID: 31609763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma.
    Chen D; Zhang Z; Mao C; Zhou Y; Yu L; Yin Y; Wu S; Mou X; Zhu Y
    Cell Immunol; 2014; 289(1-2):91-6. PubMed ID: 24747824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.
    Zou ZW; Ma C; Medoro L; Chen L; Wang B; Gupta R; Liu T; Yang XZ; Chen TT; Wang RZ; Zhang WJ; Li PD
    Oncotarget; 2016 Sep; 7(38):61741-61754. PubMed ID: 27557514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.